Skip Navigation

This Article
Right arrow Print PDF (9252K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Adema, G. J.
Right arrow Articles by Baas, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adema, G. J.
Right arrow Articles by Baas, P. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1990, Vol. 18, No. 18 5365-5373
© 1990


MOLECULAR BIOLOGY

Uridine branch acceptor is a cis-acting element involved in regulation of the alternative processing of calcitonin/CGRP-I pre-mRNA

Gosse J. Adema*, Karen L. van Hulst and Pieter D. Baas

Institute of Molecular Biology and Medical Biotechnology, and Laboratory for Physiological Chemistry, University of Utrecht Padualaan 8, 3584 CH, Utrecht, The Netherlands

*To whom correspondence should be addressed

Received July 17, 1990. Revised August 20, 1990. Accepted August 20, 1990.

The human calcitonin/CGRP-l (CALC-I) gene contains 6 exons and encodes two polypeptide precursors. In thyroid C-cells, calcitonin (CT) mRNA is produced by splicing of exons 1-2-3 to exon 4 (CT-encoding) and polyadenylation at exon 4. CGRP-I mRNA is produced in particular neural cells by splicing of exons 1-2-3 to exon 5 (CGRP-k-encoding) and the polyadenylated exon 6. We previously reported that model precursor RNAs containing the exon 3 to exon 5 region of the CALC-I gene are processed predominantly into CGRP-I mRNA in vitro, in nuclear extracts of several cell types (neural and non-neural). Using truncated precursor RNAs containing only the exon 3 to exon 4 region of the CALC-I gene it was shown that CT splicing is an inefficient reaction in which a uridine residue serves as the major site of lariat formation. Here we report that the low CT splicing efficiency and the dominance of CGRP-I splicing over CT splicing in vitroare primarily due to the usage of the CT-specific uridine branch acceptor. Mutation of this uridine residue into an adenosine residue resulted in a strong increase in CT splicing efficiency causing a reversal of the splicing pattern. In addition, it was shown that this point mutation also increased CT splicing efficiency in vivo. These results and data obtained from other experiments involving mutation of the CT splice acceptor site suggest that the uridine branch acceptor is a cis-acting element involved in regulation of the alternative processing of the CALC-I pre-mRNA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
T. Osaki, T. Katafuchi, and N. Minamino
Genomic and Expression Analysis of Canine Calcitonin Receptor-stimulating Peptides and Calcitonin/Calcitonin Gene-related Peptide
J. Biochem., October 1, 2008; 144(4): 419 - 430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H.-L. Zhou and H. Lou
Repression of Prespliceosome Complex Formation at Two Distinct Steps by Fox-1/Fox-2 Proteins
Mol. Cell. Biol., September 1, 2008; 28(17): 5507 - 5516.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H.-L. Zhou, A. P. Baraniak, and H. Lou
Role for Fox-1/Fox-2 in Mediating the Neuronal Pathway of Calcitonin/Calcitonin Gene-Related Peptide Alternative RNA Processing
Mol. Cell. Biol., February 1, 2007; 27(3): 830 - 841.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Zhu, R. A. Hasman, V. A. Barron, G. Luo, and H. Lou
A Nuclear Function of Hu Proteins as Neuron-specific Alternative RNA Processing Regulators
Mol. Biol. Cell, December 1, 2006; 17(12): 5105 - 5114.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. H. Hovhannisyan and R. P. Carstens
A Novel Intronic cis Element, ISE/ISS-3, Regulates Rat Fibroblast Growth Factor Receptor 2 Splicing through Activation of an Upstream Exon and Repression of a Downstream Exon Containing a Noncanonical Branch Point Sequence
Mol. Cell. Biol., January 1, 2005; 25(1): 250 - 263.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
J. R. ROESSER
Both U2 snRNA and U12 snRNA are required for accurate splicing of exon 5 of the rat calcitonin/CGRP gene
RNA, August 1, 2004; 10(8): 1243 - 1250.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Messina, D. M. T. Yu, G. W. Both, P. L. Molloy, and B. G. Robinson
Calcitonin-Specific Transcription and Splicing Targets Gene-Directed Enzyme Prodrug Therapy to Medullary Thyroid Carcinoma Cells
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1310 - 1318.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. L. Thomas, M. Lock, J. M. Zabolotny, B. R. Mohan, and N. W. Fraser
The 2-Kilobase Intron of the Herpes Simplex Virus Type 1 Latency-Associated Transcript Has a Half-Life of Approximately 24 Hours in SY5Y and COS-1 Cells
J. Virol., January 15, 2002; 76(2): 532 - 540.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. Lou and R. F. Gagel
Alternative Ribonucleic Acid Processing in Endocrine Systems
Endocr. Rev., April 1, 2001; 22(2): 205 - 225.
[Abstract] [Full Text]


Home page
Microbiol. Mol. Biol. Rev.Home page
J. Zhao, L. Hyman, and C. Moore
Formation of mRNA 3' Ends in Eukaryotes: Mechanism, Regulation, and Interrelationships with Other Steps in mRNA Synthesis
Microbiol. Mol. Biol. Rev., June 1, 1999; 63(2): 405 - 445.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H Lou, R F Gagel, and S M Berget
An intron enhancer recognized by splicing factors activates polyadenylation.
Genes & Dev., January 15, 1996; 10(2): 208 - 219.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.